BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26714930)

  • 1. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
    Wu F; Chen WJ; Yan L; Tan GQ; Li WT; Zhu XJ; Ge XC; Liu JW; Wang BL
    Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway.
    Wu F; Su SC; Tan GQ; Yan L; Li TY; Zhang HL; Yu JS; Wang BL
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):592-601. PubMed ID: 28291626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
    Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
    Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
    Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.
    Zhong A; Zhang H; Xie S; Deng M; Zheng H; Wang Y; Chen M; Lu R; Guo L
    Oncol Rep; 2018 Apr; 39(4):1747-1756. PubMed ID: 29393493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
    PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
    Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
    Ji YB; Ling N; Zhou XJ; Mao YX; Li WL; Chen N
    Asian Pac J Cancer Prev; 2014; 15(8):3651-7. PubMed ID: 24870773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
    Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.
    Yu YS; Tang ZH; Pan QC; Chen XH; Liu XN; Zang GQ
    Cancer Chemother Pharmacol; 2012 May; 69(5):1173-80. PubMed ID: 22237956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.
    Ma JL; Zeng S; Zhang Y; Deng GL; Shen H
    Tumour Biol; 2016 May; 37(5):6177-84. PubMed ID: 26614432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
    Huang H; Hu M; Zhao R; Li P; Li M
    Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells.
    Yuan Z; Guo W; Yang J; Li L; Wang M; Lei Y; Wan Y; Zhao X; Luo N; Cheng P; Liu X; Nie C; Peng Y; Tong A; Wei Y
    J Biol Chem; 2015 Jun; 290(24):14927-44. PubMed ID: 25918161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.